Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Genevieve Boland

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Cancer Research|May 3, 2017
Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy ResponseBenjamin M Larimer, Eric Wehrenberg-Klee, Frank Dubois, et al.
American Journal of Lifestyle Medicine|March 10, 2023
Incorporating Well-Being into Mentorship Meetings: A Case Demonstration at Massachusetts General Hospital Department of Surgery a Harvard Medical School AffiliateBeth Frates, David Cron, Carrie Cunningham Lubitz, et al.
Frontiers in Oncology|June 13, 2020
Integration of Digital Pathologic and Transcriptomic Analyses Connects Tumor-Infiltrating Lymphocyte Spatial Density With Clinical Response to BRAF InhibitorsArturas Ziemys, Michelle Kim, Alexander M Menzies, et al.
Immunotherapy Advances|July 22, 2021
Type 2 immunity is maintained during cancer-associated adipose tissue wastingPatrick J Lenehan, Assunta Cirella, Amiko M Uchida, et al.
Annals of Surgical Oncology|October 29, 2024
Society of Surgical Oncology Consensus Statement: Assessing the Evidence for and Utility of Gene Expression Profiling of Primary Cutaneous MelanomaEdmund K Bartlett, Cristina O'Donoghue, Genevieve Boland, et al.
JAMA Dermatology|April 15, 2026
Cutaneous Eruptions and Lifileucel/Interleukin 2 in Individuals With Metastatic MelanomaJordan T Said, Yunxi Li, Nakisa Sadeghi, et al.
Cancer Immunology, Immunotherapy : CII|March 14, 2019
Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibitionVylyny Chat, Robert Ferguson, Danny Simpson, et al.
Nature Medicine|August 22, 2018
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanomaNoam Auslander, Gao Zhang, Joo Sang Lee, et al.
Nature Medicine|October 19, 2018
Publisher Correction: Robust prediction of response to immune checkpoint blockade therapy in metastatic melanomaNoam Auslander, Gao Zhang, Joo Sang Lee, et al.
Oncoimmunology|March 17, 2023
Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentationsBenjamin C Park, Sathya Narayanan, Alexander Gavraldis, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Cancer Research|May 3, 2017
Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy ResponseBenjamin M Larimer, Eric Wehrenberg-Klee, Frank Dubois, et al.
American Journal of Lifestyle Medicine|March 10, 2023
Incorporating Well-Being into Mentorship Meetings: A Case Demonstration at Massachusetts General Hospital Department of Surgery a Harvard Medical School AffiliateBeth Frates, David Cron, Carrie Cunningham Lubitz, et al.
Frontiers in Oncology|June 13, 2020
Integration of Digital Pathologic and Transcriptomic Analyses Connects Tumor-Infiltrating Lymphocyte Spatial Density With Clinical Response to BRAF InhibitorsArturas Ziemys, Michelle Kim, Alexander M Menzies, et al.
Immunotherapy Advances|July 22, 2021
Type 2 immunity is maintained during cancer-associated adipose tissue wastingPatrick J Lenehan, Assunta Cirella, Amiko M Uchida, et al.
Annals of Surgical Oncology|October 29, 2024
Society of Surgical Oncology Consensus Statement: Assessing the Evidence for and Utility of Gene Expression Profiling of Primary Cutaneous MelanomaEdmund K Bartlett, Cristina O'Donoghue, Genevieve Boland, et al.
JAMA Dermatology|April 15, 2026
Cutaneous Eruptions and Lifileucel/Interleukin 2 in Individuals With Metastatic MelanomaJordan T Said, Yunxi Li, Nakisa Sadeghi, et al.
Cancer Immunology, Immunotherapy : CII|March 14, 2019
Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibitionVylyny Chat, Robert Ferguson, Danny Simpson, et al.
Nature Medicine|August 22, 2018
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanomaNoam Auslander, Gao Zhang, Joo Sang Lee, et al.
Nature Medicine|October 19, 2018
Publisher Correction: Robust prediction of response to immune checkpoint blockade therapy in metastatic melanomaNoam Auslander, Gao Zhang, Joo Sang Lee, et al.
Oncoimmunology|March 17, 2023
Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentationsBenjamin C Park, Sathya Narayanan, Alexander Gavraldis, et al.
Pageof 5